Tech Company Financing Transactions
NextCODE Funding Round
NextCODE secured a $15 million Series A funding round on 10/24/2013. Investors included Arch Venture Partners and Polaris Partners.
Transaction Overview
Company Name
Announced On
10/24/2013
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Proceeds Purpose
The funding will allow NextCODE to rapidly scale the integration of its genomics services into clinical settings.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 Main St. 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
NextCODE Health is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. Using technology developed over more than 16 years at deCODE genetics, we are enabling the widespread incorporation of genome sequence data into patient diagnosis and care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Brainin
Chief Financial Officer
John Long
Chief Information Officer
Hakon Gudbjartsson
Chief Scientific Officer
Jeffrey Gulcher
Chief Technical Officer
Hongye Sun
Vice President
Louis Yuan
VP - Bus. Development
Alex Fowkes
Browse more venture capital transactions:
Prev: 10/24/2013: Applauze venture capital transaction
Next: 10/24/2013: FieldLens venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs